Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
D000109:Acetylcholine / Q000378:metabolism*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001923:Brain Chemistry / Q000187:drug effects; D001933:Brain Stem / Q000378:metabolism; D002230:Carbidopa / Q000494:pharmacology; D002540:Cerebral Cortex / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism*; D003913:Dextroamphetamine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004149:Dioxoles / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D006220:Haloperidol / Q000494:pharmacology; D006624:Hippocampus / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D010868:Pimozide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D013788:Thalamus / Q000378:metabolism; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D003984:Dibenzazepines; D004149:Dioxoles; D010879:Piperazines; D011743:Pyrimidines; D011955:Receptors, Drug; D010868:Pimozide; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D006220:Haloperidol; D002230:Carbidopa; D001058:Apomorphine; D000109:Acetylcholine; D003913:Dextroamphetamine; D002746:Chlorpromazine; D004298:Dopamine